Hemodynamic Diagnostic System

A new impedance cardiography (ICG) noninvasive hemodynamic diagnostic system is designed for the assessment of cardiovascular functioning.

The AcQtrac ICG system provides rapid, reliable information enabling doctors to assess and treat advanced heart failure, hypertension, and other cardiovascular diseases. The system's noninvasive monitors are safer, more efficient, and more cost-effective to use than it noninvasive counterparts, according to Vasamed, which developed the system.

"The AcQtrac ICG is unique in its class since it provides a waveform ‘image' of the heart that serves as a diagnostic aid and helpful tool in guiding drug therapy management,” said Paulita LaPlante, president of Vasamed (Minneapolis, MN, USA), which developed the AcQtrac system. "As a woman, I am particularly focused on the tragedy that more women die of cardiovascular disease annually than they do from breast cancer. In fact more women than men in the United States die of heart disease and stroke.”

Research has shown that it is more difficult to diagnose cardiovascular disease in women. Vasamed intends to offer medical strategies and solutions that improve outcomes for women as well as all other patients. The company anticipates marketing its new diagnostic tool to heart-failure clinics, private cardiology offices, critical care monitoring units, emergency departments, and pediatric cardiology specialists.




Related Links:
Vasamed